-transparent.png){kind=logo}
The cation and structural requirements of the intracellular inhibitory "P" site of adenylate cyclase were investigated in human platelet membranes, bovine sperm particles, and detergent-solubilized and purified preparations from rat and bovine brain. Sensitivity of adenylate cyclase to P site-mediated inhibition was enhanced by reversible and irreversible activators of the enzyme. The most effective sensitization of the platelet and brain adenylate cyclases was observed with Mn2+ and upon proteolysis with inhibin in the presence of guanosine 5'-O-(3-thiotriphosphate). These resulted in IC50 values for (2',5'dideoxy-adenosine (2',5'-dd-Ado) and 2'-deoxy-3'-AMP of approximately 1-2 microM. The data were consistent with the ideas that P site-mediated inhibition of adenylate cyclase is dependent on divalent cation and is a function of enzyme activity. A number of nucleosides and nucleotides were synthesized and used to define structural requirements for P site-mediated inhibition of a detergent-solubilized adenylate cyclase from rat brain. The data suggest a strict requirement for an intact adenine moiety and a beta-glycosidic linkage for the ribosyl moiety. 2'-Deoxy-and especially 2',5'-dideoxy-ribosyl moieties enhanced sensitivity and a strong preference for phosphate at the 3'-position was exhibited. Substitutions at the 5'-ribose position impaired sensitivity. The order of potency and IC50 values of the more potent adenosine analogs were 2',5'-dideoxy-3'-AMP (congruent to 0.1 microM) greater than 2'-deoxy-3'-AMP (congruent to 1 microM) greater than 2',5'-dd-Ado (congruent to 3 microM) greater than 3'-AMP (congruent to 9 microM) greater than 2'-deoxy-adenosine (congruent to 15 microM) greater than adenosine (congruent to 80 microM). Large substitutions at the 3'-ribose position were tolerated, e.g., dApdN di- and dAp(dN)4 penta-nucleotides and succinyl- and p-fluoro-sulfonyl-benzoyl- moieties. The purified adenylate cyclase from bovine brain was inhibited by P site agonists with IC50 values of 34 and 45 microM for 2'-deoxy-3'-AMP and 2',5'-dd-Ado, respectively. The data imply, first, that the locus of the P site is the catalytic subunit of adenylate cyclase and, second, that the increased sensitivity observed with Mn2+ is due to an effect of the cation on the catalytic subunit. In contrast with adenylate cyclases from other mammalian tissues, the enzyme from bovine sperm exhibited only weak sensitivity to P site agonists; 2'-deoxy-3'-AMP congruent to 2',5'-dd-Ado greater than adenosine, each with IC50 values greater than 1000 microM.(ABSTRACT TRUNCATED AT 400 WORDS)
R A Johnson, and
S M Yeung, and
D Stübner, and
M Bushfield, and
I Shoshani
July 1990,
The Journal of biological chemistry,
R A Johnson, and
S M Yeung, and
D Stübner, and
M Bushfield, and
I Shoshani
October 1991,
Biochemical pharmacology,
R A Johnson, and
S M Yeung, and
D Stübner, and
M Bushfield, and
I Shoshani
January 2004,
Biochimica et biophysica acta,
R A Johnson, and
S M Yeung, and
D Stübner, and
M Bushfield, and
I Shoshani
April 1995,
Molecular pharmacology,
R A Johnson, and
S M Yeung, and
D Stübner, and
M Bushfield, and
I Shoshani
October 1994,
Neuropharmacology,
R A Johnson, and
S M Yeung, and
D Stübner, and
M Bushfield, and
I Shoshani
November 2000,
Biochemistry,
R A Johnson, and
S M Yeung, and
D Stübner, and
M Bushfield, and
I Shoshani
January 1983,
Biochemical pharmacology,
R A Johnson, and
S M Yeung, and
D Stübner, and
M Bushfield, and
I Shoshani
October 1982,
Biochemical pharmacology,
R A Johnson, and
S M Yeung, and
D Stübner, and
M Bushfield, and
I Shoshani
January 1991,
European journal of biochemistry,
R A Johnson, and
S M Yeung, and
D Stübner, and
M Bushfield, and
I Shoshani
January 1982,
Journal of interferon research,
